Anatomical and functional responses to single brolucizumab injection in neovascular age-related macular degeneration patients not responding to antiangiogenics: a case series

INTRODUCTION: Neovascular age-related macular degeneration (nAMD) is treated with antivascular endothelial growth factor (anti-VEGF) drugs. However, resistance to anti-VEGF therapy is observed in some patients. Brolucizumab is a new-generation anti-VEGF drug for the treatment of nAMD, with proven ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuccarini, Silvio, Puce, Fabrizio, Crisà, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AboutScience 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961812/
https://www.ncbi.nlm.nih.gov/pubmed/35360670
http://dx.doi.org/10.33393/dti.2022.2343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961812/
https://www.ncbi.nlm.nih.gov/pubmed/35360670
http://dx.doi.org/10.33393/dti.2022.2343

Ejemplares similares